MicroRNA-134 as a potential plasma biomarker for the diagnosis of acute pulmonary embolism
Abstract Background Acute pulmonary embolism (APE) remains a diagnostic challenge due to a variable clinical presentation and the lack of a reliable screening tool.MicroRNAs (miRNAs) regulate gene expression in a wide range of pathophysiologic processes.Circulating miRNAs are emerging biomarkers in heart failure, type 2 diabetes and other disease s